Home |
About Us |
Investor Relations |
Products & Services |
Science & Technology |
People |
News & Events |
Contact Us
News |
Events
|
|
 |
|
||
 |
||
| |
|
 |
 |
23 November 2007 Director Share Purchases Cyprotex PLC (AIM: CRX), the drug discovery technology and information
company was notified today that Robert Morrison Atwater, the Chairman
and Chief Executive of the Company purchased a total of 175,000 ordinary
shares of 0.1p each in the Company on 22 November 2007 at the following
price per share: 75,000 shares at 3.74p; 50,000 shares at 3.78p; and
50,000 shares at 4.00p. Robert Morrisson Atwater now has a total interest
of 1,610,000 ordinary shares in the Company, which represents 1.16%
of the issued share capital of the Company. For further information:
|
|
|
 |
|
 |
Legal
Disclaimer |